Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23
While causality cannot be demonstrated, declining incidence and prevalence rates of NTM were observed during the study period in which HEMT was introduced. Improved respiratory outcomes were observed in those with NTM-PD. These findings support reconsideration of current treatment thresholds for NTM-PD in CF in the context of the HEMT era.
Authors
- Majbritt Jeppesen
- Daniel Faurholt‐Jepsen (ORCID: https://orcid.org/0000-0001-8561-0155)
- Bibi U Nielsen
- Helle Krogh Johansen (ORCID: https://orcid.org/0000-0003-0268-3717)
- Peter Østrup Jensen (ORCID: https://orcid.org/0000-0003-1648-7186)
- Camilla Bjørn Jensen (ORCID: https://orcid.org/0000-0002-8224-4601)
- Christian Leo‐Hansen (ORCID: https://orcid.org/0000-0003-2004-6404)
- Mette Kolpen (ORCID: https://orcid.org/0000-0001-5575-0384)
- Thomas Bryrup (ORCID: https://orcid.org/0000-0001-8533-6766)
- Tavs Qvist (ORCID: https://orcid.org/0000-0002-1725-5312)
- Tacjana Pressler (ORCID: https://orcid.org/0000-0002-6434-4975)
- Mette Frahm Olsen (ORCID: https://orcid.org/0000-0002-5742-6403)
- Niels Høiby (ORCID: https://orcid.org/0000-0002-1347-725X)
Institutions
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Journal of Cystic Fibrosis
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1016/j.jcf.2025.12.008
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vertex Pharmaceuticals